The eye in neurological disease

Lancet

Volumn 364, Issue 9450, 2004, Pages 2045-2054

  Miller, Neil R ^a,c   Newman, Nancy J ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b EMORY UNIVERSITY   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1A INTERFERON; CHOLINERGIC RECEPTOR BLOCKING AGENT; COCAINE; CORTICOSTEROID; HYDROXYAMPHETAMINE; METHYLPREDNISOLONE; PREDNISONE; STEROID;

ANTERIOR EYE CHAMBER; CHOROID; CHOROID DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; CONJUNCTIVA; CONJUNCTIVA DISEASE; CORNEA; CORNEA DISEASE; EARLY DIAGNOSIS; HUMAN; IRIS; IRIS DISEASE; LENS; LENS DISEASE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE; OPTIC NERVE DISEASE; PRIORITY JOURNAL; PUPIL DISEASE; RETINA; RETINA DISEASE; RISK ASSESSMENT; SCLERA DISEASE; VISUAL DISORDER; VITREOUS BODY; VITREOUS DISEASE;

EID: 9944240340     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)17517-X     Document Type: Conference Paper

References (87)

1. Miller NR, Newman NJ, eds. Walsh and Hoyt's clinical neuro-ophthalmology, 5th edn. Baltimore: Williams & Wilkins, 1998.
2. Barquet N, Domingo P, Cayla JA, et al. Prognostic factors in meningococcal disease: development of a bedside predictive model and scoring system. JAMA. 278:1997;491-496
3. Chang CH, Lin KH, Sheu MM, Huang WL, Wang HZ, Chen CW. The change of etiological agents and clinical signs of epidemic viral conjunctivitis over an 18-year period in southern Taiwan. Graefes Arch Clin Exp Ophthalmol. 241:2003;554-560
4. Insler MS, Helm C, Napoli S. Conjunctival hamartoma in neurofibromatosis. Am J Ophthalmol. 99:1985;731-733
5. Farr AK, Shalev B, Crawford TO, Lederman HM, Winkelstein JA, Repka MX. Ocular manifestations in ataxia-telangiectasia. Am J Ophthalmol. 134:2002;891-896
6. Miller NR. Carotid-cavernous sinus fistulas. In: Miller NR, Newman NJ, eds. Walsh and Hoyt's clinical neuroophthalmology, 5th edn, vol 3. Baltimore: Williams & Wilkins, 1998: 3263-22.
7. Arigon V, Binaghi M, Sabouret C, et al. Usefulness of systematic ophthalmologic investigations in neurofibromatosis 1: a cross-sectional study of 211 patients. Eur J Ophthalmol. 12:2002;413-418
8. Liu M, Cohen EJ, Brewer GJ, Laibson PR. Kayser-Fleischer ring as the presenting sign of Wilson disease. Am J Ophthalmol. 133:2002;832-834
9. Tabery HM. Morphology of epithelial keratitis in herpes zoster ophthalmicus: a non-contact photomicrographic in vivo study in the human cornea. Acta Ophthalmol Scand. 78:2000;651-655
10. Chang JH, Wakefield D. Uveitis: a global perspective. Ocul Immunol Inflamm. 10:2002;263-279
11. Thean JH, Hall AJ, Stawell RJ. Uveitis in herpes zoster ophthalmicus. Clin Experiment Ophthalmol. 29:2001;406-410
12. Tsai T, O'Brien JM. Masquerade syndromes: malignancies mimicking inflammation in the eye. Int Ophthalmol Clin. 42:2002;115-131
13. Ganley JP. Uveitis and multiple sclerosis: an overview. Saari KM. Uveitis update. 1984;345-349 Excerpta Medica, Amsterdam
14. Biousse V, Trichet C, Bloch-Michel E, Roullet E. Multiple sclerosis associated with uveitis in two large clinic-based series. Neurology. 52:1999;179-181
15. Friedman JM. Neurofibromatosis 1: clinical manifestations and diagnostic criteria. J Child Neurol. 17:2002;548-554
16. Mustonen E, Poyhonen M, Leisti E-L. Neuro-ophthalmological findings in neurofibromatosis: clinical and neuroradiological study of 125 patients. Neuro-ophthalmology. 17:1997;117-126
17. Knox DL. Ocular manifestations of cervical vascular disease. Surv Ophthalmol. 13:1969;245-262
18. Thompson HS, Miller NR. Disorders of pupillary function, accommodation and lacrimation. In: Miller NR, Newman NJ, eds. Walsh and Hoyt's clinical neuro-ophthalmology, 5th edn, vol 1. Baltimore: Williams & Wilkins, 1998: 961-1040.
19. Chan CC, Paine M, O'Day J. Carotid dissection: a common cause of Horner's syndrome. Clin Experiment Ophthalmol. 29:2001;411-415
20. Lee AG, Hayman LA, Brazis PW. The evaluation of isolated third nerve palsy revisited: an update on the evolving role of magnetic resonance, computed tomography, and catheter angiography. Surv Ophthalmol. 47:2002;137-157
21. Ragge NK, Baser ME, Riccardi VM, et al. The ocular presentation of neurofibromatosis 2. Eye. 11:1997;12-18
22. Goyal V, Tripathi M. Sunflower cataract in Wilsons's disease. J Neurol Neurosurg Psychiatry. 69:2000;133
23. Deguti MM, Tietge UJ, Barbosa ER, Cancado EL. The eye in Wilson disease: sunflower cataract associated with Kayser-Fleischer ring. J Hepatol. 37:2002;700
24. Giordano M, Comoli AM, De Angelis MS, Mutani R, Sebastiani F, Richiardi PM. Reassessment of the specificity of lens opacities in myotonic dystrophy. Ophthalmic Res. 28:1996;224-229
25. Chan RY, Yannuzzi LA, Foster CS. Ocular Whipple's disease: earlier definitive diagnosis. Ophthalmology. 108:2001;2225-2231
26. Arnold AC, Pepose JS, Hepler RS, Foos RY. Retinal periphlebitis and retinitis in multiple sclerosis. Ophthalmology. 91:1984;255-262
27. Zierhut M, Foster CS. Multiple sclerosis, sarcoidosis, and other diseases in patients with pars planitis. Dev Ophthalmol. 23:1992;41-47
28. Lawrence PF, Oderich GS. Ophthalmologic findings as predictors of carotid artery disease. Vasc Endovascular Surg. 36:2002;415-424
29. Gonzalez-Gay MA, Garcia-Porrua C, Llorca J, et al. Visual manifestations of giant cell arteritis: trends and clinical spectrum in 161 patients. Medicine. 79:2000;283-292
30. Kattah JC, Wang DZ, Reddy C. Intravenous recombinant tissue-type plasminogen activator thrombolysis in treatment of central retinal artery occlusion. Arch Ophthalmol. 120:2002;1234-1236
31. Schmidt DP, Schulte-Montig J, Schumacher M. Prognosis of central retinal artery occlusion: local intraarterial fibrinolysis versus conservative treatment. AJNR Am J Neuroradiol. 23:2002;1301-1307
32. Shibuya M, Suzuki Y, Takayasu M, Sugita K. Effects of STA-MCA anastomosis for ischaemic oculopathy due to occlusion of the internal carotid artery. Acta Neurochir. 103:1990;71-75
33. Carter JE. Panretinal photocoagulation for progressive ocular neovascularization secondary to occlusion of the common carotid artery. Ann Ophthalmol. 16:1984;572-576
34. Abu El-Asrar AM, Abdel Gader AG, Al-Amro SA, Al-Attas OS. Hyperhomocysteinemia and retinal vascular occlusive disease. Eur J Ophthalmol. 12:2003;495-500
35. Carbone J, Sanchez-Ramon S, Cobo-Soriano R, et al. Antiphospholipid antibodies: a risk factor for occlusive retinal vascular disorders - comparison with ocular inflammatory diseases. J Rheumatol. 28:2001;2437-2441
36. O'Halloran HS, Pearson PA, Lee WB, Susac JO, Berger JR. Microangiopathy of the brain, retina and cochlea (Susac syndrome): a report of 5 cases and a review of the literature. Ophthalmology. 105:1998;1038-1044
37. Papo T, Biousse V, LeHoang P, et al. Susac syndrome. Medicine. 77:1998;3-11
38. Cotlier E. Café-au-lait spots of the fundus in neurofibromatosis. Arch Ophthalmol. 95:1977;1990-1993
39. Muci-Mendoza R, Ramella M, Fuenmayor-Rivera D. Corkscrew retinal vessels in neurofibromatosis type 1: report of 12 cases. Br J Ophthalmol. 86:2002;282-284
40. Onder F, Cosar CB, Akbatur H, Kural G. Bilateral retinal involvement as a presenting sign of neurofibromatosis 2. J Pediatr Ophthalmol Strabismus. 39:2002;49-51
41. Rowley SA, O'Callaghan FJ, Osborne JP. Ophthalmic manifestations of tuberous sclerosis: a population-based study. Br J Ophthalmol. 85:2001;420-423
42. Luchesse N, Goldberg MF. Iris and fundus changes in tuberous sclerosis. J Pediatr Ophthalmol Strabismus. 18:1981;45-46
43. Vine AK. Severe periphlebitis, peripheral retinal ischemia, and preretinal neovascularization in patients with multiple sclerosis. Am J Ophthalmol. 113:1992;28-32
44. Engell T. Neurological disease activity in multiple sclerosis patients with periphlebitis retinae. Acta Neurol Scand. 73:1986;168-172
45. Tola MR, Granieri E, Casetta I, et al. Retinal periphlebitis in multiple sclerosis: a marker of disease activity? Eur Neurol. 33:1993;93-96
46. Birch MK, Barbosa S, Blumhardt LD, O'Brien C, Harding SP. Retinal venous sheathing and the blood-retinal barrier in multiple sclerosis. Arch Ophthalmol. 114:1996;34-39
47. Thorne JE, Galetta SL. Optic disc edema and retinal periphlebitis as the initial manifestation of sarcoidosis. Arch Neurol. 55:1998;862-864
48. Repka MX. Degenerative and metabolic diseases in infants and children. In: Miller NR, Newman NJ, eds. Walsh and Hoyt's clinical neuro-ophthalmology, 5th edn, vol 2. Baltimore: Williams & Wilkins, 1998: 2811-66.
49. Park DW, Boldt HC, Massicotte SJ, et al. Subacute sclerosing panencephalitis manifesting as viral retinitis: clinical and histopathologic findings. Am J Ophthalmol. 123:1997;533-542
50. Caruso JM, Robbins-Tien D, Brown WD, Antony JH, Gascon GG. Atypical chorioretinitis as an early presentation of subacute sclerosing panencephalitis. J Pediatr Ophthalmol Strabismus. 37:2000;119-122
51. Ong TJ, Paine M, O'Day J. Retinal manifestations of ophthalmic artery hypoperfusion. Clin Experiment Ophthalmol. 30:2002;284-291
52. Desai UR, Tawansy KA, Joondeph BC, Schiffman RM. Choroidal granulomas in systemic sarcoidosis. Retina. 21:2001;40-47
53. Rattray KM, Cole MD, Smith SR. Systemic non-Hodgkin's lymphoma presenting as a serpiginous choroidopathy: report of a case and review of the literature. Eye. 14:2000;706-710
54. Biswas J, Shome D. Choroidal tubercles in disseminated tuberculosis diagnosed by the polymerase chain reaction in aqueous humor: a case report and review of the literature. Ocul Immunol Inflamm. 10:2002;293-298
55. Yasunari T, Shiraki K, Hattori H, Miki T. Frequency of choroidal abnormalities in neurofibromatosis type 1. Lancet. 356:2000;988-992
56. Celebi S, Alagoz G, Aykan U. Ocular findings in Sturge-Weber syndrome. Eur J Ophthalmol. 10:2000;239-243
57. Susac JO, Smith JL, Scelfo RJ. The "tomato-catsup" fundus in Sturge-Weber syndrome. Arch Ophthalmol. 92:1974;69-70
58. Severson EA, Baratz KH, Hodge DO, Burke JP. Herpes zoster ophthalmicus in Olmstead County, Minnesota: have systemic antivirals made a difference? Arch Ophthalmol. 121:2003;386-390
59. Riono WP, Hidayat AA, Rao NA. Scleritis: a clinicopathologic study of 55 cases. Ophthalmology. 106:1999;1328-1333
60. Miller NR. Papilledema. In: Miller NR, Newman NJ, eds. Walsh and Hoyt's clinical neuro-ophthalmology, 5th edn, vol 1. Baltimore: Williams & Wilkins, 1998: 487-548.
61. Chan JW. Optic neuritis in multiple sclerosis. Ocul Immunol Inflamm. 10:2002;161-186
62. Optic Neuritis Study Group. The clinical profile of optic neuritis. Arch Ophthalmol. 109:1991;1673-1678
63. Beck RW, Cleary PA, Anderson MM. Jr, et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. N Engl J Med. 326:1992;581-588
64. Beck RW, Trobe JD, Moke PS, et al. High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol. 121:2003;944-949
65. Wakakura M, Mashimo K, Oono S, et al. Multicenter clinical trial for evaluating methylprednisolone pulse treatment of idiopathic optic neuritis in Japan: Optic Neuritis Treatment Trial Multicenter Cooperative Research Group (ONMRG). Jpn J Ophthalmol. 43:1999;133-138
66. Jacobs LD, Beck RW, Simon JH, et al. Intramuscular interferon-beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. N Engl J Med. 343:2000;898-904
67. Newman NJ. Multiple sclerosis and related demyelinating diseases. In: Miller NR, Newman NJ, eds. Walsh and Hoyt's clinical neuro-ophthalmology, 5th edn, vol 5. Baltimore: Williams & Wilkins, 1998: 5539-676.
68. Katz JM, Bruno MK, Winterkorn JM, Nealon N. The pathogenesis and treatment of optic disc swelling in neurosarcoidosis: a unique therapeutic response to inflixamab. Arch Neurol. 60:2003;426-430
69. Jacobson DM. Lyme disease and optic neuritis: long-term follow-up of seropositive patients. Neurology. 60:2003;881-882
70. Ormerod LD, Dailey JP. Ocular manifestations of cat scratch disease. Curr Opin Ophthalmol. 10:1999;209-216
71. Murat Sumer M, Yuksel D, Ozdemir I. Neurosyphilis presenting with optic neuropathy. Ann Neurol. 32:2000;30-32
72. Amitava AK, Alarm S, Hussain R. Neuro-ophthalmic features in pediatric tubercular meningoencephalitis. J Pediatr Ophthalmol Strabismus. 38:2001;229-234
73. Ashworth B. Chronic demyelinating optic neuritis: a reappraisal. Neuro-ophthalmology. 7:1987;75-79
74. Morrissey SP, Borruat FX, Miller DH, et al. Bilateral simultaneous optic neuropathy in adults: clinical, imaging, serological, and genetic studies. J Neurol Neurosurg Psychiatry. 58:1995;70-74
75. Kelman SE. Ischemic optic neuropathies. In: Miller NR, Newman NJ, eds. Walsh and Hoyt's clinical neuro-ophthalmology, 5th edn, vol 1. Baltimore: Williams & Wilkins, 1998: 549-98.
76. Sadda SR, Nee M, Miller NR, Biousse V, Newman NJ, Kouzis A. Clinical spectrum of posterior ischemic optic neuropathy. Am J Ophthalmol. 132:2001;743-750
77. Arnold AC. Pathogenesis of nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol. 23:2002;157-163
78. The Ischemic Optic Neuropathy Decompression Trial Research Group. Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. JAMA. 273:1995;625-632
79. Foroozan R, Deramo VA, Buono LM, et al. Recovery of visual function in patients with biopsy-proven giant cell arteritis. Ophthalmology. 110:2003;539-542
80. Hayreh SS, Zimmerman B, Kardon RH. Visual improvement with corticosteroid therapy in giant cell arteritis: report of a large study and review of literature. Acta Ophthalmol Scand. 80:2002;355-367
81. Sadun AA, Bassi CJ. Optic nerve damage in Alzheimer's disease. Ophthalmology. 97:1990;9-17
82. Carroll WM, Kriss A, Baraitser M, Barrett G, Halliday AM. The incidence and nature of visual pathway involvement in Friedreich's ataxia: a clinical and visual evoked potential study of 22 patients. Brain. 103:1980;413-434
83. Carelli V, Ross-Cisneros FN, Sadun AA. Optic nerve degeneration and mitochondrial dysfunction: genetic and acquired optic neuropathies. Neurochem Int. 40:2002;573-584
84. Bataller L, Dalmau J. Neuro-ophthalmology and paraneoplastic syndromes. Curr Opin Neurol. 17:2004;3-8
85. Buhmann C, Gbadamosi J, Heesen C. Visual recovery in a man with the rare combination of mtDNA 11778 LHON mutation and a MS-like disease after mitoxantrone therapy. Acta Neurol Scand. 106:2002;236-239
86. Jun AS, Brown MD, Wallace DC. A mitochondrial DNA mutation at nucleotide pair 14459 of the NADH dehydrogenase subunit 6 gene associated with maternally-inherited Leber hereditary optic neuropathy and dystonia. Proc Natl Acad Sci USA. 91:1994;6206-6210
87. Treft RL, Sanborn GE, Carey J, et al. Dominant optic atrophy, ptosis, ophthalmoplegia, dystaxia, any myopathy: a new syndrome. Ophthalmology. 91:1984;908-915